Single Nucleotide Polymorphisms (SNPs) of FCγRIIA and FCγRIIIA in Patients with Diffuse Large B-Cell Lymphoma Have No Impact On Treatment Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP with and without Rituximab: Results From the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymhoma Study Group (DSHNHL)

被引：0
|
作者：
Ahlgrimm, Manfred
Regitz, Evi [1 ]
Preuss, Klaus-Dieter [1 ]
Grass, Sandra
Poeschel, Viola [2 ]
Kreuz, Markus [3 ]
Pfreundschuh, Michael
机构：
[1] Univ Saarland, Sch Med, Jose Carreras Ctr Immuno & Gene Therapy, Dept Internal Med 1, D-6650 Homburg, Germany
[2] DSHNHL, Homburg, Saar, Germany
[3] IMISE, Leipzig, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1521 / 1521
页数：1
相关论文
共 50 条
  • [31] Peg-filgrastim (Peg-F) on day 4 of (R-)CHOP-14 chemotherapy compared to day 2 in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results of a randomized trial of the German high-grade non-Hodgkin's lymphoma study group (DSHNHL)
    Hartmann, F.
    Zeynalova, S.
    Nickenig, C.
    Reiser, M.
    Lengfelder, E.
    Duerk, H.
    de Witt, M.
    Schubert, J.
    Loeffler, M.
    Pfreundschuh, M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population
    Levy, Debora
    Bellesso, Marcelo
    Oliveira-Souza, Pamela
    Maciel, Felipe V.
    Pereira, Juliana
    Bydlowski, Sergio P.
    CLINICS, 2011, 66 (05) : 919 - 922
  • [33] Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): An update.
    Habermann, TM
    Weller, E
    Morrison, VA
    Cassileth, PA
    Cohn, J
    Dakhil, S
    Gascoyne, RD
    Woda, B
    Fisher, R
    Peterson, BA
    Horning, SJ
    BLOOD, 2004, 104 (11) : 40A - 40A
  • [34] Exploratory Study on the Relationship Between FcγRIIIa Gene Polymorphisms and the Efficacy and Toxicity of Rituximab in the Treatment of Stage I/II Diffuse Large B-Cell Lymphoma
    Wuxiao, Zhijun
    Wang, Hua
    Su, Qunhao
    Zhou, Haiyan
    Hu, Min
    Tao, Shi
    Xu, Lu
    Chen, Yu
    Hao, Xinbao
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (05) : 615 - 622
  • [35] Clinical relevance of genomic aberrations in diffuse large B-cell lymphoma -: An analysis within a multicentric treatment trial of the German High Grade Lymphoma Study Group (DSHNHL).
    Bentz, M
    Kloess, M
    Baudis, M
    Feller, AC
    Ott, G
    Enz, M
    Trümper, LH
    Pfreundschuh, M
    Lichter, P
    Döhner, H
    BLOOD, 2001, 98 (11) : 464A - 464A
  • [36] MYC NUMERICAL ABERRATIONS UNFAVORABLY IMPACT ON DISEASE OUTCOME IN PATIENTS WITH DIFFUSE LARGE B-CELL AND HIGH-GRADE LYMPHOMA
    Schieppati, F.
    Fisogni, S.
    Balzarini, P.
    Re, A.
    Peli, A.
    Passi, A.
    Roccaro, A.
    Lorenzi, L.
    Facchetti, F.
    Rossi, G.
    Tucci, A.
    HAEMATOLOGICA, 2017, 102 : 17 - 18
  • [37] Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (vol 32, pg 4127, 2014)
    Pfreundschuh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1991 - 1991
  • [38] Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma.: An update of the GELA study.
    Coiffier, B
    Fermé, C
    Hermine, O
    Haioun, C
    Baumelou, E
    Solal-Celigny, P
    Delmer, A
    Sebban, C
    Mounier, N
    Tertian, G
    Van Hoof, A
    Bosly, A
    BLOOD, 2001, 98 (11) : 725A - 725A
  • [39] Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Choi, Yoo Duk
    Jung, Sung-Hoon
    Yhim, Ho-Young
    Kwak, Jae-Yong
    Park, Ho Sung
    Shin, Myung-Geun
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (09) : 774 - 779
  • [40] Estimating the impact of rituximab on bcl-2-associated resistance to CHOP using competing risks in elderly patients with diffuse large B-cell lymphoma (DLBCL).
    Mounier, N.
    Briere, J.
    Gisselbrecht, C.
    Lederlin, P.
    Berger, F.
    Bosly, A.
    Tilly, H.
    Reyes, F.
    Gaulard, P.
    Coiffier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 425S - 425S
12345